# A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

> **NCT00736073** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 73 (actual)

## Conditions studied

- Pancreatitis

## Interventions

- **DRUG:** aprepitant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00736073
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-08
- **Final completion:** 2012-11
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2015-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736073, "A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00736073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*